TMU RCCTM
The TMU Research Center of Cancer Translational Medicine integrates resources from within and outside the university to focus on cancer drug development, precision diagnostics, and personalized medicine. Utilizing AI technology, the center promotes innovative cancer therapies, establishes specialized research teams, cultivates physician-scientists and basic researchers, and advances the development of core facilities. In the 2025 , we will concentrate on four major research directions:
- Application of organ
- Biomarkers and therapies for complications arising from cancer treatment
- Development of small-molecule targeted drugs
- RNA-based therapies and biomarker discovery
Director
Jang-Yang Chang, M.D
-
- Chair Professor, College of Medicine, Taipei Medical University
- Director, Research Center of Cancer Translational Medicine, Taipei Medical University
